Bionano Genomics, Inc. (BMV:BNGO)
Mexico flag Mexico · Delayed Price · Currency is MXN
87.83
0.00 (0.00%)
At close: Apr 25, 2025, 2:00 PM CST

Bionano Genomics Statistics

Total Valuation

BMV:BNGO has a market cap or net worth of MXN 255.85 million. The enterprise value is 604.45 million.

Market Cap 255.85M
Enterprise Value 604.45M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +123.37%
Shares Change (QoQ) +15.05%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 2.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.40
PB Ratio 0.35
P/TBV Ratio 0.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.26
EV / Sales 1.00
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.42

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.77.

Current Ratio 1.06
Quick Ratio 0.38
Debt / Equity 0.77
Debt / EBITDA n/a
Debt / FCF -0.40
Interest Coverage -37.46

Financial Efficiency

Return on equity (ROE) is -170.33% and return on invested capital (ROIC) is -40.02%.

Return on Equity (ROE) -170.33%
Return on Assets (ROA) -32.76%
Return on Invested Capital (ROIC) -40.02%
Return on Capital Employed (ROCE) -193.96%
Revenue Per Employee 6.48M
Profits Per Employee -23.58M
Employee Count 100
Asset Turnover 0.21
Inventory Turnover 1.79

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.74% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -88.74%
50-Day Moving Average 83.76
200-Day Moving Average 339.83
Relative Strength Index (RSI) 60.05
Average Volume (20 Days) 22

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 3.48

Income Statement

In the last 12 months, BMV:BNGO had revenue of MXN 641.29 million and -2.33 billion in losses. Loss per share was -1,836.46.

Revenue 641.29M
Gross Profit 7.92M
Operating Income -1.59B
Pretax Income -2.33B
Net Income -2.33B
EBITDA -1.30B
EBIT -1.59B
Loss Per Share -1,836.46
Full Income Statement

Balance Sheet

The company has 197.43 million in cash and 568.80 million in debt, giving a net cash position of -371.36 million.

Cash & Cash Equivalents 197.43M
Total Debt 568.80M
Net Cash -371.36M
Net Cash Per Share n/a
Equity (Book Value) 737.12M
Book Value Per Share 395.16
Working Capital 44.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.44 billion and capital expenditures -2.15 million, giving a free cash flow of -1.44 billion.

Operating Cash Flow -1.44B
Capital Expenditures -2.15M
Free Cash Flow -1.44B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 1.23%
Operating Margin -247.85%
Pretax Margin -363.87%
Profit Margin n/a
EBITDA Margin -202.29%
EBIT Margin -247.85%
FCF Margin n/a

Dividends & Yields

BMV:BNGO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -123.37%
Shareholder Yield -123.37%
Earnings Yield -912.31%
FCF Yield -562.16%

Stock Splits

The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.0166666667.

Last Split Date Jan 27, 2025
Split Type Reverse
Split Ratio 0.0166666667

Scores

BMV:BNGO has an Altman Z-Score of -14.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -14.84
Piotroski F-Score n/a